Talis Biomedical Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TLIS Nasdaq 8731 https://talisbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Talis Biomedical Corp

Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director - May 23rd, 2023 12:00 pm
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results - May 11th, 2023 8:05 pm
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023 - May 4th, 2023 12:00 pm
Talis Announces Fourth Quarter and Full Year 2022 Financial Results - Mar 22nd, 2023 8:05 pm
Talis Biomedical Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags - Nov 9th, 2022 11:13 am
Talis Biomedical Reports Third Quarter 2022 Financial Results - Nov 3rd, 2022 8:05 pm
Talis Biomedical Stops Work On COVID-19 Assay, Cuts Workforce - Aug 3rd, 2022 11:50 am
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results - Aug 2nd, 2022 8:05 pm